Old Web
English
Sign In
Acemap
>
authorDetail
>
David G. Osterman
David G. Osterman
Bayer
High-throughput screening
Pharmacology
Drug discovery
Pharmaceutical industry
Molecular biology
3
Papers
77
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
High-Throughput Mass Spectrometry Screening for Inhibitors of Phosphatidylserine Decarboxylase
2007
Journal of Biomolecular Screening
Chris D. Forbes
Joshuaine G. Toth
Can C. Ozbal
William A. LaMarr
Jennifer A. Pendleton
Sandra Rocks
Richard W. Gedrich
David G. Osterman
James A. Landro
Kevin Lumb
Show All
Source
Cite
Save
Citations (34)
HTS in the new millennium
2000
Journal of Pharmacological and Toxicological Methods
James A. Landro
Ian Taylor
William G. Stirtan
David G. Osterman
James Kristie
Edward J. Hunnicutt
Peter Rae
Paul M. Sweetnam
Show All
Source
Cite
Save
Citations (0)
HTS in the new millennium: The role of pharmacology and flexibility
2000
Journal of Pharmacological and Toxicological Methods
James A. Landro
Ian Taylor
William G. Stirtan
David G. Osterman
James Kristie
Edward J. Hunnicutt
Peter Rae
Paul M. Sweetnam
Show All
Source
Cite
Save
Citations (43)
1